Seeing Is Believing
with an average price target of $7.62. This is a potential upside of $7.62 (0%) from yesterday's end of day stock price of $0.
Momenta Pharmaceuticals's activity chart (see below) currently has 56 price targets and 37 ratings on display.
Analysts average stock forecasts to be materialized ratio is 94.7% with an average time for these price targets to be met of 297.45 days.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 25-Aug-2020. First documented stock forecast 08-Jan-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$50
4 years 11 months 5 days ago
(25-Aug-2020)
11/11 (100%)
$19.95 (66.39%)
190
Hold
$45
4 years 11 months 6 days ago
(24-Aug-2020)
7/7 (100%)
$20.74 (85.49%)
287
Hold
$47
4 years 11 months 10 days ago
(20-Aug-2020)
5/5 (100%)
$18.45 (64.62%)
320
Hold
$42
$-10.48 (-19.97%)
$42
4 years 11 months 11 days ago
(19-Aug-2020)
3/4 (75%)
$-10.12 (-19.42%)
27
Buy
$20
4 years 11 months 27 days ago
(03-Aug-2020)
5/5 (100%)
$1.18 (8.57%)
246
What is MNTA (Momenta Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on MNTA (Momenta Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on MNTA (Momenta Pharmaceuticals)?
Which analyst is the currently most bullish on MNTA (Momenta Pharmaceuticals)?
Which analyst is the currently most reserved on MNTA (Momenta Pharmaceuticals)?